Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diamedica Therapeutics Inc 301 CARLSON PARKWAY SUITE 210 MINNETONKA MN 55305 USA

www.diamedica.com P: 763-496-5454

Description:

DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.

Key Statistics

Overview:

Market Capitalization, $K 92,997
Enterprise Value, $K 88,457
Shares Outstanding, K 37,958
Annual Sales, $ 0 K
Annual Net Income, $ -19,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,160 K
EBIT, $ -21,270 K
EBITDA, $ -22,460 K
60-Month Beta 1.69
% of Insider Shareholders 7.20%
% of Institutional Shareholders 10.12%
Float, K 35,225
% Float 92.80%
Short Volume Ratio 0.34

Growth:

1-Year Return 65.36%
3-Year Return -73.94%
5-Year Return -27.94%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 18.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 03/19/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.62
EPS Growth vs. Prev Qtr -16.67%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DMAC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -40.07%
Return-on-Assets % -37.90%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.87
Book Value/Share 1.35
Interest Coverage -1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar